Your search for smoking cessation returned 180 results

N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.

Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group.

High quality communication in tobacco treatment programs with lung cancer screenings was significantly associated with self-efficacy for smoking cessation.

Guideline offers simple practice changes that may increase effectiveness of tobacco-dependence pharmacotherapy.

One-year abstinence higher with e-cigarettes than other nicotine replacement products

E-cigarette use was 9.8% among current smokers, 1.1% among former smokers, and 0.6% among nonsmokers.

The authors note that e-cigarettes seem to double the likelihood of achieving abstinence and are as effective as nicotine replacement therapy for supporting cessation.

No evidence that varenicline, bupropion, or nicotine replacement increase probability of abstinence

Overall, 22.7 percent received smoking cessation pharmacotherapy, most often the nicotine patch

Ninety-seven percent of smoking patients with MI received counseling, but few have SCM use